Senti Biosciences, Inc. (SNTI)
NASDAQ: SNTI · Real-Time Price · USD
0.8793
-0.0207 (-2.30%)
Mar 24, 2026, 3:41 PM EDT - Market open
Senti Biosciences Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
34
Market Cap
23.12M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | 2.56M | -1.73M | -40.25% |
| Dec 31, 2022 | 4.29M | 1.53M | 55.23% |
| Dec 31, 2021 | 2.76M | 2.20M | 387.81% |
| Dec 31, 2020 | 566.00K | 481.00K | 565.88% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Cue Biopharma | 27.47M |
| Neuphoria Therapeutics | 14.99M |
| Barinthus Biotherapeutics | 14.97M |
| Marker Therapeutics | 3.55M |
| Longeveron | 1.20M |
| Vistagen Therapeutics | 789.00K |
SNTI News
- 1 day ago - Senti Biosciences to Present Clinical and Translational Data on SENTI-202 at the 11th Annual Innate Killer Conference - GlobeNewsWire
- 21 days ago - Senti Biosciences to Present at Leerink Partners 2026 Global Healthcare Conference - GlobeNewsWire
- 4 weeks ago - Senti Biosciences to Present at TD Cowen 46th Annual Health Care Conference - GlobeNewsWire
- 4 weeks ago - Senti Bio Participates in Cell & Gene Live Event Highlighting Cutting-Edge Technologies Advancing Cell Therapy Development - GlobeNewsWire
- 5 weeks ago - Senti Biosciences Completes Enrollment in Phase 1 Clinical Trial of SENTI-202 for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia (R/R AML) - GlobeNewsWire
- 7 weeks ago - Senti Biosciences Selected for On-Stage Presentation at Healthcare Conference Taipei 2026 - GlobeNewsWire
- 2 months ago - Senti Biosciences Participates in Virtual Investor CEO Connect Segment to Discuss the Company's Groundbreaking AML Data at the American Society of Hematology Annual Meeting and Recently Granted RMAT Designation - GlobeNewsWire
- 2 months ago - Senti Bio to Participate in Panel Presentation at Biotech Showcase Alongside the J.P. Morgan Annual Healthcare Conference - GlobeNewsWire